Regrettably, I’m not in Boston for the DIA Conference

This year I missed out on the Drug Information Association (DIA) conference but hopefully I can attend in 2014.  The fact that I am not attending didn’t stop me from browsing the conference schedule for the DIA 2013 49th Annual Meeting.  Yesterday, I posted a list of the sessions, panels, tutorials, and roundtables I would have been interested to check out the first several days of the conference.

If I did go to DIA this year – Part II

If I did go to the  conference this year, here is some of the content I might have selected for the final two days from the 4 day agenda. Pleas also check out my picks from Sunday 6/23 to Tuesday 6/25.

Wednesday, June 26th

Use of ePRO Instruments in Clinical Trials
June 26, 8:00AM – 9:30AM

Study Startup Symposium
June 26, 10:15AM – 11:45AM

EDC Insights: Before, During, and After
June 26, 10:15AM – 11:45AM

Using Competence Models to Drive High Quality Drug Project Management
June 26, 1:45PM – 3:15PM

TransCelerate’s Collaborative Approach to Risk-based Monitoring: The Methodology
June 26, 1:45PM – 3:15PM

Ethical Issues in Clinical Trials
June 26, 4:00PM – 5:30PM

Noninferiority Trials in Drug Development: Clinical, Statistical and Regulatory Perspectives
June 26, 4:00PM – 5:30PM

Thursday, June 27th

eSource Symposium
June 27, 9:00AM – 10:30AM

Some Innovative Approaches to Handling Missing Data Problems in Clinical Trials
June 27, 9:00AM – 10:30AM

Implementing a Paperless Trial for Phase 3: A Biotech’s Lessons Learned
June 27, 10:45AM – 12:15PM

Off-target Blood Pressure Changes and Evaluation in Drug Development: Safety, Clinical and Regulatory Considerations
June 27, 10:45AM – 12:15PM

CDER Town Hall: Part 1 of 2
June 27, 9:00AM – 10:30AM
CDER Town Hall: Part 2 of
June 27, 10:45AM – 12:15PM

Student Posters

Mon, Jun 24 10:00AM

• Comparison of European Drug Approvals to US
• Update of Current Compliance With Required Reporting of Summary Results on ClinicalTrials.gov

Other Posters

Tue, Jun 25 11:45AM

• Site-level Quality Assurance Outcome: Identification of Sponsor-provided Source Documents With Greatest Prevalence of Errors
• Potential Differences in Subjects From Physician Recruitment Versus Centralized Recruitment Campaigns in a Clinical Trial
• Risk-based Centralized Monitoring of Clinical Trials: A Statistical Approach
• The Use of Compliant Text Messaging to Increase Patient Engagement in a Study Comparing Oral Contraceptive Symptoms
• Determinants for Predicting Serious Adverse Event (SAE) Rates Across Study Duration in Selected CNS Indications Wed, Jun 26 11:45AM

Are you attending the conference?

If there are other don’t miss sessions, you are welcome to contact me so I can consider adding them to my overview list.  If you attended the conference and are open to networking on any of the topics then I’d love to hear from you via email or in the comments.

One final regret

I’m totally bummed I won’t be able to drop by the Medidata booth to check out their DeLorean.  So cool!

More from the Clinical Operations Toolkit (June 2013):

• I Should Have Gone to DIA (Part 1)
  
• EDC Wishlist
  
• Risk-Based Monitoring